- Home
- MCBS vs KURA Comparison
MCBS vs KURA Comparison
Compare MCBS & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MCBS | KURA |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 816.1M | 744.0M |
| IPO Year | 2019 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MCBS | KURA |
|---|---|---|
| Price | $28.99 | $8.69 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 10 |
| Target Price | ★ $32.00 | $25.88 |
| AVG Volume (30 Days) | 99.4K | ★ 1.4M |
| Earning Date | 04-17-2026 | 04-30-2026 |
| Dividend Yield | ★ 3.44% | N/A |
| EPS Growth | ★ 4.76 | N/A |
| EPS | ★ 2.64 | N/A |
| Revenue | N/A | ★ $67,482,000.00 |
| Revenue This Year | $36.78 | $62.31 |
| Revenue Next Year | $4.83 | $58.09 |
| P/E Ratio | $11.03 | ★ N/A |
| Revenue Growth | N/A | ★ 25.24 |
| 52 Week Low | $24.24 | $5.41 |
| 52 Week High | $31.00 | $12.49 |
Technical Indicators
Market Signals| Indicator | MCBS | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 59.33 | 54.83 |
| Support Level | $28.40 | $7.99 |
| Resistance Level | $30.38 | $9.60 |
| Average True Range (ATR) | 0.70 | 0.40 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 87.56 | 84.64 |
Price Performance
Historical ComparisonAbout MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.